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Abstract
Cardiovascular disease (CVD) risk factors increase with menopause, which coincides with a
reduction in endothelial function. Our previous work indicates that sedentary peri- and
postmenopausal women have different endothelial responses to acute exercise. High
cardiorespiratory fitness is protective of endothelial function; however, whether this protection
remains during and after the menopausal transition is unclear.
Objective: To evaluate if there are differences in endothelial function before and after acute
exercise in women at different menopausal stages with high and low cardiorespiratory fitness.
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Methods: Participants were healthy high fit premenopausal (n=11), perimenopausal (n=12) and
postmenopausal women (n=13) and low-fit perimenopausal (n=7) and postmenopausal women
(n=8). Brachial artery flow-mediated dilation (FMD) was measured before and after acute
moderate intensity exercise. FMD was calculated as (Diameterpeak-Diameterbaseline)/
Diameterbaseline)*100. Differences between high-fit women and between high and low-fit
perimenopausal and postmenopausal women were assessed with repeated-measure ANOVAs.
Relations with FMD were assessed with Pearson correlations.
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Results: FMD was reduced with progressive menopausal stage in high-fit women (p=0.005) and
was lower in perimenopausal compared to postmenopausal women (p=0.047). FMD was lower in
high-fit compared to low-fit women (p=0.006) and there was no relation between FMD and
VO2peak (p>0.05). There was an inverse relation between FMD and follicle stimulating hormone
(p<0.05), but not estradiol (p>0.05).
Conclusions: These data suggest that endothelial function is lower with progressive menopausal
stage in women with high cardiorespiratory fitness; that FMD is lower in women with higher
cardiorespiratory fitness; and that FSH, but not estradiol, is associated with FMD.

Corresponding Author: Corinna Serviente, 226 Noll Lab, University Park, PA 16802, cfs150@psu.edu, Phone: 814-865-1235, Fax:
814-865-1275,.
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Introduction:
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Cardiovascular disease (CVD) is the leading cause of death in women in developed
countries and accounts for approximately 400,000 deaths per year in women in the United
States1. In the years leading up to and following menopause, or the cessation of ovarian
function, risk factors for cardiovascular disease (CVD) increase dramatically2,3. The
increase in CVD risk has been attributed to the reduction in estrogen and increase in follicle
stimulating hormone (FSH) that accompany menopause4. The progression of subclinical
cardiovascular risk factors also accelerates during the menopausal transition5 and these
factors may develop in the absence of increases in traditional CVD risk factors6,7.
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Endothelial dysfunction, assessed via flow-mediated dilation (FMD), is a subclinical risk
factor for CVD8 and has been shown to be prognostic of cardiovascular events in
postmenopausal women9. Flow-mediated dilation is reduced with age in women; however,
the menopausal transition is a time when the age-related decline in FMD may
accelerate10,11. Postmenopausal women appear to have lower FMD than premenopausal
women12–14 and Moreau et al. reported a stepwise reduction in FMD with advancing
menopausal stage. Importantly, FMD was more strongly related to menopausal stage than
age15, suggesting that menopause has an independent effect on the reported decline in
endothelial function. Identifying factors that may contribute to and alter the decline in
endothelial function associated with menopause can help target future therapeutic treatments
for midlife women.
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Exercise is generally considered beneficial for endothelial function and CVD risk; however,
it is unknown whether habitual physical activity and high levels of cardiorespiratory fitness
are protective of the decline in FMD with progressive menopausal stage. Two cross-sectional
analyses showed no differences in FMD in trained vs. sedentary postmenopausal
women14,16, but perimenopausal women have not been evaluated. We have previously
shown that healthy, but not habitually active peri- and postmenopausal women had different
endothelial responses to an acute bout of moderate intensity exercise17. These data suggest
that there may be changes in endothelial function during the menopausal transition that
become apparent in response to the acute cardiovascular challenge of exercise in healthy
women. However, it is unknown whether the FMD response to exercise is different by
menopausal stage in habitually active and highly fit women. Therefore, the aims of this
study were to evaluate whether there is a decline in endothelial function with menopause in
women with high cardiorespiratory fitness and to evaluate whether endothelial function is
different in high- versus low-fit perimenopausal and postmenopausal women before or after
an acute bout of exercise.
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Methods:
Healthy high-fit premenopausal (n=11), perimenopausal (n=12), and postmenopausal
women (n=13) were recruited for this study. An a priori sample size estimation for our
primary aim, the effect of menopausal status on FMD in high-fit women, was calculated in
G*power, with a power of 0.80 and an alpha of 0.05. This analysis revealed that 11
participants were needed per group to detect differences in FMD between women in each
menopausal stage and between peri- and postmenopausal women following an acute bout of
exercise. To evaluate the effects of fitness on FMD, data from low-fit perimenopausal (n=7)
and postmenopausal women (n=8) from our prior study17 were included.
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All participants were between 40 and 65 years old and were non-smokers. Participants were
excluded according to resting blood pressure (>140/>90 mmHg), fasting plasma lipids
(LDL-C >160 mg/dl, HDL-C <40 mg/dl, TG> 150 mg/dl), and fasting plasma glucose (>126
mg/dl). Lipid cut points were selected according to ATP-III Guidelines18. Participants were
also excluded if they reported a history of cardiovascular diseases, long-term menstrual
irregularities, breast cancer with radiation or chemotherapy treatment, vaginal bleeding,
abnormal uterine/ovary anatomy that negatively impacted fertility, if they used medications
and/or supplements that are known to influence endothelial function, or if they had any
exercise limitations.
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Menopausal status was defined using STRAW+1019 criteria based on self-reported
menstrual cycle. Premenopausal women were experiencing regular menstrual cycles,
perimenopausal women were experiencing irregular cycles or 2–11 months of amenorrhea,
and postmenopausal women had experienced at least 5 years of amenorrhea. All participants
had not taken hormone therapy or oral contraceptives within the 6 months prior to study
enrollment. Postmenopausal women had to undergo natural menopause to qualify for the
study. Follicle stimulating hormone (FSH, Abcam, Cambridge, UK) and estrogen (17-beta–
estradiol, Life Technologies, Frederick, MD) were measured in all participants as a
complement to menstrual cycle criteria. Measures were taken on the same day as assessment
of FMD. Estradiol and FSH were not evaluated in 2 low-fit perimenopausal women, as
blood samples were not obtained in these participants. The coefficient of variation for these
assays was 0.1% and 1.1%, respectively.
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Cardiorespiratory fitness was determined using a treadmill VO2max. test. Not all participants
met the criteria for a maximal exercise test (i.e. plateau in VO2), therefore data are reported
as VO2peak. High-fit participants had to achieve a VO2peak of at least the 80th percentile for
their age, based on American College of Sports Medicine percentiles20. Low-fit participants
had an average VO2peak of approximately the 40th percentile for their age. Self-reported
physical activity levels were assessed via the International Physical Activity Questionnaire
(IPAQ). Low-fit participants did not meet the 2008 Physical Activity Guidelines (150
minutes/week of moderate intensity activity, 75 minutes/week of vigorous intensity activity,
or an equivalent combination of the two, accumulated in 10 minute bouts21). High-fit
participants were, on average, at least doubling physical activity guidelines and had been
doing so for a minimum of 2 years prior to study enrollment. After initial screenings, each
participant completed three study visits. The University of Massachusetts Amherst
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Institutional Review Board approved all study protocols and participants signed an informed
consent document before beginning the study.
Study Overview
On the first visit, participants underwent a dual energy x-ray absorptiometry scan (DEXA) to
assess body composition, anthropometric measurements, a blood pressure screening, and
measurements of fasting plasma glucose and cholesterol. During the second visit,
participants underwent an FMD familiarization trial and a ramped treadmill VO2max test
(Parvo Medics TrueOne 2400, Sandy, UT) with 12 lead electrocardiogram. Heart rate and
VO2 data from the test were used to prescribe exercise intensity on the third visit.
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On the third visit, participants underwent 2 initial FMD measures. Following FMD
measures, they were fitted with a chest-worn heart rate monitor (Polar FT1, Polar Electro,
Lake Success, NY) and then exercised on a treadmill for 30 min at the heart rate
corresponding to 60–64% VO2peak. Throughout the exercise session blood pressure and rate
of perceived exertion were assessed every 2 min. Workload was adjusted as necessary to
maintain the desired heart rate. Each session began and ended with a 5 min warm-up and
cool-down. Following the exercise session, participants rested for 30 min and then
underwent 2 post-exercise FMD measures.
Flow-mediated Dilation

Author Manuscript

Brachial artery flow-mediated dilation (FMD) was measured following established
guidelines22 and as previously published17. Briefly, participants were tested following a
three-day low nitrate diet. Participants refrained from taking vitamins/supplements for 72
hours, from consuming alcohol or caffeine for 12 hours, and from consuming any foods or
beverages, with the exception of water, for at least 6 hours prior to the visit. Participants did
not engage in any exercise for 12 hours prior to the testing visit. Menstruating women (i.e.
early perimenopausal and premenopausal women) were measured between menstrual cycle
days one and six.

Author Manuscript

All FMD measurements took place in a quiet temperature-controlled room and began in the
morning. The study began following a 10 min supine rest. Measurements were recorded on
the non-dominant arm with an ultrasound and Doppler probe (Philip’s HD11XE Ultrasound
System, Bothell, WA) with a 60° insonation angle, placed proximal to an inflatable cuff on
the participant’s forearm (D. E. Hokanson, Bellevue, WA). Blood pressure was measured on
the dominant arm every minute using an automatic blood pressure cuff and heart rate was
recorded throughout the study with a 3-lead electrocardiogram (GE Dash 2000, Friedurg,
Germany). Throughout the study, brachial artery diameter was continuously tracked during 2
min baseline, 5 min forearm cuff occlusion (200 mmHg), and 4 min following cuff release.
The average variance for repeated FMD trials before and after exercise was 0.1%.
Data Analysis:
All statistical analyses were completed in SPSS v24 with a significance level of α=0.05. All
data were evaluated for adherence to the assumptions of each statistical test. Some variables
were not normally distributed due to a few extreme data points. Analyses were performed
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with and without these values included. Given that the outcomes were the same, analyses
from all participants are reported. Differences in baseline characteristics were assessed using
one-way ANOVAs, t-tests, or an equivalent non-parametric test. Body mass index was
natural log transformed in perimenopausal women. Differences were evaluated between
high- and low-fit women within the perimenopausal and postmenopausal groups and
between high-fit premenopausal, perimenopausal, and postmenopausal women.
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All FMD trials were analyzed using Cardiovascular Suite Software (FMD Studio, Quipu,
Pisa, Italy). Each trial was evaluated to determine the average baseline and peak diameter
achieved during the study. FMD was calculated as (Diameterpeak-Diameterbaseline)/
Diameterbaseline) * 100. Pre-exercise and post-exercise trials were averaged. Differences in
FMD parameters were evaluated using repeated measure ANOVAs and post-hoc testing.
Repeated measures were used to account for the repeated measurements of FMD before and
after acute exercise. To evaluate the influence of menopausal status on FMD, differences
were assessed in high-fit premenopausal, perimenopausal, and postmenopausal women.
FMD data was not obtained in one premenopausal participant due to equipment failure.
Post-hoc testing was used to evaluate each group’s response to acute exercise and any
differences between groups. To evaluate the overall effect of fitness and menopausal status
on FMD, differences were assessed in high and low-fit perimenopausal and postmenopausal
women. Post-hoc testing was used to evaluate each group’s response to acute exercise and to
evaluate differences within each menopausal stage (e.g. high vs. low-fit perimenopausal).
Pearson correlations were used to assess whether VO2peak, age, FSH, or estradiol were
related to FMD in all participants. Relations between FSH, estradiol, and body fat
percentage were also evaluated. Data are presented as mean±SEM.
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Results
Participant characteristics:
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Participants were healthy, had few risk factors for cardiovascular disease, and had similar
characteristics across menopausal stage and fitness categories (Table 1). Within high-fit
women, there was a significant difference in age across all groups (p<0.05), though the
overall age range was only 16 years. All other risk factors were similar across high fit
premenopausal, perimenopausal, and postmenopausal women, with the exception of lower
FSH in premenopausal women compared with peri- and post-menopausal women, higher
HDL-C in postmenopausal compared to premenopausal women, and lower estradiol in
postmenopausal compared to premenopausal women. Within perimenopausal women, the
only differences between groups were lower body fat percentage (p=0.001) and body mass
index (BMI, p=0.046), and higher time spent in moderate-to-vigorous physical activity
(MVPA, p<0.001) and VO2peak (p<0.001) in high-fit women. There was also a trend for a
difference in age (p=0.053) in perimenopausal women. Within postmenopausal women, the
only differences were higher MVPA (p<0.001), VO2peak (p<0.001), and HDL-C (p=0.005)
and lower body weight (p=0.03) and body fat percentage (p<0.001) in high-fit women. In all
participants, there was no relation between body fat percentage and FSH (r=0.001, p=0.99)
or estradiol (r=0.13, p=0.36).
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There was a main effect of menopausal status on FMD within high-fit women (p=0.005)
with lower FMD in the postmenopausal compared to the premenopausal group (p=0.004,
Figure 1). There were no significant changes in FMD with exercise in any of the high-fit
groups. In high- and low-fit perimenopausal and postmenopausal women, there was also a
main effect of menopausal status (p=0.047), with lower FMD in postmenopausal compared
to perimenopausal women.
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To evaluate the effect of fitness, we compared FMD before and after exercise between highand low-fit peri- and postmenopausal women (Figure 2A). There was a main effect of fitness
on FMD in perimenopausal and postmenopausal women (p=0.006), with lower FMD in high
vs. low fit women. In perimenopausal women, there was no difference in FMD before
exercise (high: 6.1±0.9%, low: 6.4±1.2%, p=0.83); however, in response to acute exercise,
low-fit perimenopausal women had significantly higher FMD compared to high-fit
perimenopausal women (high: 5.5±0.7%, low: 8.5±0.9%, p=0.021). In postmenopausal
women, there was a difference between fitness groups in FMD before (high: 4.2±0.9%, low:
6.5±1.1%, p=0.043), but only a trend toward a significant difference after acute exercise
(high: 4.2±0.7 %, low: 6.2±0.9% p=0.08). There was no relation between VO2peak and FMD
(pre-exercise: r=−0.12, p=0.42; post-exercise: r=−0.11, p=0.46, Figure 2B). There was no
difference in baseline artery diameter within or between groups at any time point (Table 2).
In all participants combined, pre- and post-exercise FMD were negatively related to age
(pre-exercise: r=−0.33, p=0.020; post-exercise: age: r=−0.45, p=0.001) and FSH (preexercise: r=−0.43 p=0.002; post-exercise, r=−0.37, p=0.009, Figure 3A), but not estradiol
(pre-exercise: r=0.16, p=0.29; post-exercise: r=0.20, p=0.16, Figure 3B).
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Discussion
This study aimed to determine whether there was a decline in FMD with menopause in
habitually active women with high cardiorespiratory fitness and to evaluate the influence of
cardiorespiratory fitness on the FMD response to acute exercise in peri- and postmenopausal
women. The findings were: 1) there was a decrease in FMD with progressive menopausal
stage in highly-fit women, 2) high cardiorespiratory fitness was not related to higher FMD in
healthy peri- or postmenopausal women, 3) cardiorespiratory fitness affected the FMD
response to acute exercise in perimenopausal women, and 4) follicle stimulating hormone
(FSH), but not estradiol was negatively related to FMD. These data suggest that there is
reduced endothelial function with progressive menopausal stage and that this reduction is
present in women with high cardiorespiratory fitness.
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Moreau et al., reported a progressive decline in FMD with advancing menopausal stage15,
while cross-sectional analyses demonstrated lower FMD in postmenopausal compared to
premenopausal women12–14. Importantly, these studies generally evaluated women with low
levels of cardiorespiratory fitness. Given the evidence supporting the protective influence of
habitual physical activity and high fitness on vascular aging in men16,23,24, we hypothesized
that highly fit women would not experience a reduction in FMD based on menopausal stage.
Contrary to our hypothesis, we found that highly-fit postmenopausal women had lower
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function than highly-fit premenopausal women, suggesting that fitness does not attenuate the
decline in FMD with menopause.
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Regular endurance exercise and higher cardiorespiratory fitness are associated with optimal
endothelial function; however, in midlife and older adults, this relation may differ based on
sex. Pierce and colleagues demonstrated that active 55–79 year-old men had greater FMD
than their sedentary counterparts, whereas postmenopausal active women did not. They also
demonstrated a lack of improvement in FMD with 8 weeks of exercise training in sedentary
postmenopausal women, while men improved FMD significantly with training16. The sex
difference in the association between FMD and cardiorespiratory fitness in healthy
individuals may be due to changes that occur with menopause. Findings from studies
evaluating the FMD response to exercise training in postmenopausal women are equivocal.
Some studies have reported improvements in FMD with training25,26, while others have
shown no benefit of training on FMD16,27,28. Our recent review of this literature suggests
that improvements in FMD due to exercise training may only occur in those with greater
CVD risk burden29. In healthy women with low CVD risk, FMD appears to be more
influenced by menopausal stage. The present analysis supports this hypothesis, as we show a
decline in FMD with menopause in healthy women, despite high levels of cardiorespiratory
fitness.
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Our results also show that high fit peri- and postmenopausal women had lower FMD than
low fit women. Most notably, average FMD in high-fit postmenopausal women was
approximately 4.2%, which would indicate clinical endothelial dysfunction30. These low
FMD values are in line with what others have reported in highly-fit postmenopausal
women14. Interestingly, we found no association between FMD and VO2peak, suggesting
that factors other than cardiorespiratory fitness are likely influencing FMD in these women.
One explanation for the low FMD values we report is that remodeling of the vasculature has
occurred in high-fit women. There is evidence to suggest that short term exercise training
improves FMD; however, over time and with continued training, remodeling of the
vasculature occurs, leading to a larger lumen:wall ratio and a lowering of FMD compared to
after initial training began31,32. These studies were primarily conducted in young healthy
men, therefore it has yet to be determined whether habitual exercise training creates the
same adaptations in midlife women. Another possibility is that high-fit women are relying
on vasodilatory factors other than nitric oxide, which FMD would not detect. The reliance
on non-nitric oxide vasodilatory factors (e.g. endothelial derived hyperpolarizing factors)
appears to increase when nitric oxide-mediated vasodilation is reduced33,34. Therefore, it is
possible that we are seeing a shift in vasodilatory capacity that is less reliant on nitric oxide
in high-fit women, leading to an overall lower FMD response. Based on these possibilities, a
lower FMD response may not indicate true endothelial dysfunction; however, this requires
future studies and investigation.
The lack of benefit of fitness on FMD through the menopausal transition may indicate that
the effects of a changing hormonal environment outweigh the effects of habitual exercise.
Estrogen has well-established effects on endothelial cells35,36. Moreau et al. reported that
postmenopausal women did not improve FMD with exercise training unless they were
supplemented with estradiol37. Interestingly, we found no association between FMD and
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estradiol, but a significant inverse relation between FSH and FMD. Follicle stimulating
hormone levels rise during perimenopause and remain elevated in postmenopause19.
Emerging evidence suggests that FSH may have an effect on CVD risk that is independent of
the effects of changing estrogen levels38,39. The relation between FSH and endothelial
function is relatively unexplored; however, women who had a lower increase in FSH through
the menopause transition had a lower risk of atherosclerosis development compared to those
with a moderate or high rise in FSH40. Endothelial dysfunction occurs early in the process of
atherosclerosis, therefore, our data showing lower FMD with higher FSH is consistent with a
potential role of FSH in vascular health. Similarly, Moore et al., reported an inverse
association between vascular conductance and FSH in women at different menopausal
stages41 and Moreau et al., reported an inverse association between FSH and FMD15.
Therefore, these data suggest that the increase in FSH with menopause may negatively
influence endothelial function. Given that postmenopausal women are exposed to
chronically high levels of FSH, this may represent an important area of investigation for
future mechanistic studies aimed at reducing CVD risk with menopause.
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Assessment of the FMD response to acute exercise provides insight into the endothelial
responsiveness to a cardiovascular challenge and may reveal differences in endothelial
function that are not otherwise apparent42,43. We have previously reported different
endothelial responses to acute moderate intensity treadmill exercise in healthy women. We
showed no difference in FMD in low-fit peri- vs. postmenopausal women before exercise;
however, perimenopausal women showed a trend for higher FMD after acute exercise17. In
the current analysis, we also found a divergent response to acute exercise in perimenopausal
women. We show that low-fit perimenopausal women had higher FMD compared with highfit women following exercise. To our knowledge, this is the first evaluation of the effect of
fitness on FMD responses to acute exercise in peri- and postmenopausal women.
The divergent response to acute exercise between low- and high-fit women may be driven by
habituation to the exercise stimulus in high-fit women. This hypothesis is supported by the
lack of FMD response to acute exercise in the high-fit premenopausal, perimenopausal, and
postmenopausal groups. Interestingly, neither the high- nor the low fit postmenopausal group
responded to acute exercise. The lack of responsiveness to acute exercise in postmenopausal
women has been shown by at least one other group. Yoo et al., reported no FMD response to
acute low, moderate or high intensity exercise in healthy postmenopausal women44.
Together with our data, this suggests that postmenopausal status, regardless of
cardiorespiratory fitness level, is associated with a lack of FMD responsiveness to acute
exercise.
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Limitations
While this study provides novel insight into differences in endothelial function based on
menopausal status and cardiorespiratory fitness, it has some limitations. This study was a
cross-sectional analysis; therefore, causation cannot be inferred from the results. Future
work evaluating these outcomes longitudinally is warranted. Participants in this study were
selected to have few risk factors for cardiovascular disease, to allow us to better evaluate the
independent effects of menopausal status and cardiorespiratory fitness on FMD, while
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limiting potential confounding factors. While this may be considered a strength of the study,
results may not be generalizable to a more diverse population. Given that menopause and
aging are strongly connected, it is possible that some of the differences that we observed
between groups were due to differences in age. In the current study, the range of ages across
groups was as narrow as possible and there was only a weak relation between FMD and age.
There was also no difference in age between high vs. low fit perimenopausal and high vs.
low-fit postmenopausal women. Based on this, we do not believe that the differences we
report are due to age. Finally, it is worth noting that sample sizes in this study were relatively
small, therefore future research is needed to corroborate these findings.

Conclusions
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Data from this study shows that there is a reduction in FMD with menopause in highly fit
women. We also found that high cardiorespiratory fitness was not associated with better
endothelial function in peri- or in postmenopausal women. Finally, we report that lower
FMD was associated with higher circulating FSH. Our results suggest that factors other than
cardiorespiratory fitness could be important targets for improving CVD risk in aging
women. It also highlights the need for further research to better understand changes in
endothelial function and the role of cardiorespiratory fitness in a menopausal population.
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Figure 1. The Influence of Menopausal Status on FMD.
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There was a main effect of menopausal status on flow-mediated dilation (FMD) in high-fit
women (n=36), with lower values in postmenopausal (n=13) compared to premenopausal
women (n=11). *compared to premenopausal group. Differences were assessed using
repeated-measure ANOVAs. Data are presented as mean±SEM.
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Figure 2. The Influence of Cardiorespiratory Fitness on FMD.

Author Manuscript

Overall, flow-mediated dilation (FMD) was lower in high-fit compared to low-fit women
and in postmenopausal compared to perimenopausal women. High-fit perimenopausal
(n=12) women had lower FMD following acute exercise compared to low-fit
perimenopausal women (n=7). High-fit postmenopausal women (n=13) had lower FMD
compared to low-fit postmenopausal women (n=8) before acute exercise (A). In all
participants, there was no association between FMD and VO2peak (B). *p<0.05. Differences
in FMD were assessed using repeated-measure ANOVAs and post-hoc testing. The
association between FMD and VO2peak was assessed with Pearson correlations. Data are
presented as mean±SEM.
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Figure 3. Associations between Sex Hormones and FMD.

In all participants (n=51), follicle stimulating hormone (FSH) was negatively related to flowmediated dilation (FMD) before and after acute exercise (A). Estradiol was not related to
FMD before or after acute exercise (B). Associations were assessed using Pearson
correlations.
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